| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |